Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Central Nervous System Neoplasms × Erlotinib Hydrochloride × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 15 Pancreatic Neoplasms 6 Neoplasms 5 Lung Neoplasms 4 Head and Neck Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Neoplasm Metastasis 2 Melanoma 2 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Respiratory Tract Diseases 1 Parotid Neoplasms 1 Papillary renal cell carcinoma, sporadic 1 Pancreatic Intraductal Neoplasms 1 Neoplasms, Unknown Primary 1 Neoplasms, Squamous Cell 1 Neoplasms, Basal Cell 1 Multiple Myeloma 1 Mouth Neoplasms 1 Lymphoma, Non-Hodgkin 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1 Liver Cirrhosis 1 Leiomyosarcoma 1 Kidney Neoplasms 1 Histiocytoma, Malignant Fibrous 1 Hereditary leiomyomatosis and renal cell cancer 1 Colorectal Neoplasms 1 Colonic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 7 Specimen Handling 6 Biopsy 6 X-Rays 4 Phantoms, Imaging 4 Nuclear Medicine Department, Hospital 4 selpercatinib 3 larotrectinib 3 Nivolumab 3 Cyclophosphamide 3 Carboplatin 3 Automobiles 3 pembrolizumab 2 fludarabine 2 erdafitinib 2 entrectinib 2 ensartinib 2 Temozolomide 2 Surveys and Questionnaires 2 Radiotherapy 2 Radiosurgery 2 Positron-Emission Tomography 2 ONC206 2 Magnetic Resonance Imaging 2 Lomustine 2 Ipilimumab 2 Etoposide 2 Cisplatin 2 ulixertinib 1 tozuleristide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡